News
-
-
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Communication financière Q1 2024/2025
Pernod Ricard reports Q1 FY25 sales decline of -5.9% organically and -8.5% reported due to China and US weakness, with unfavorable FX impact. Strong performance in Japan, Canada, Poland, Brazil, Turkey, Nigeria, and Travel Retail in Americas and Europe -
COMMUNIQUÉ DE PRESSE
Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2024
Xenetic Biosciences to present abstract at SITC 39th Annual Meeting on DNase I targeting Neutrophil Extracellular Traps for improved immune checkpoint blockade in CRC models